Madrigal Pharmaceuticals (MDGL) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Madrigal Pharmaceuticals, as the data feed reports them.

Analysts' mean target, 18 analysts
$688.78
62.5% above the price

The 18 analysts reported by the data feed have a mean price target for Madrigal Pharmaceuticals of $688.78, 62.5% above the $423.88 price (range $479.00–$962.00). 10.80% of the float was sold short as of Oct 30, 2026. Institutions hold 98.3% of the shares and insiders 5.8%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$688.78+62.5% vs price
Analysts
18
Short interest
10.80%of float, Oct 30, 2026
Short ratio
7.25 days
Institutions
98.3%
Insiders
5.79%
Beta
-1

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

18 analysts covering Madrigal Pharmaceuticals, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $423.88.

Analysts' price targets for Madrigal Pharmaceuticals
Mean price target$688.7862.5% above the price (+62.5%)
Median price target$660.0055.7% above the price (+55.7%)
Highest target$962.00127.0% above the price (+127.0%)
Lowest target$479.0013.0% above the price (+13.0%)
Analysts with a target18

Ratings this month · 19 analysts

Strong buy 3(16%)Buy 15(79%)Hold 1(5%)
Analysts' ratings of Madrigal Pharmaceuticals this month, by rating
RatingAnalystsShare
Strong buy316%
Buy1579%
Hold15%
Sell00%
Strong sell00%

The feed averages these to 1.26 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Madrigal Pharmaceuticals

Ownership of Madrigal Pharmaceuticals
Held by institutions98.3%594 institutions; percent of shares outstanding
Held by institutions, of the float104.3%
Held by insiders5.79%percent of shares outstanding
Shares outstanding23.23M
Float13.96Mshares available to trade
Insiders' net purchases, six months+33.41K8 purchases (54.68K shares), 5 sales (21.27K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Madrigal Pharmaceuticals
Shares short2.14Mas of Oct 30, 2026
Percent of float10.80%shares short ÷ float
Percent of shares outstanding9.20%shares short ÷ shares outstanding
Short ratio (days to cover)7.25shares short ÷ average daily volume

Madrigal Pharmaceuticals short interest from FINRA, with its history

Trading figures

Trading figures for Madrigal Pharmaceuticals
Beta-1movement against the market; 1 moves with it
52-week high$615.00
52-week low$353.54
Average volume, 3 months358.78Kshares a day
Average volume, 10 days889.07Kshares a day

Questions and answers

What is the analysts' price target for Madrigal Pharmaceuticals (MDGL)?

As reported by the data feed, the mean price target of the 18 analysts covering Madrigal Pharmaceuticals is $688.78, 62.5% above the latest price of $423.88. The highest target is $962.00 and the lowest $479.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Madrigal Pharmaceuticals stock?

Of the 19 ratings the data feed reports for the current month, 3 are strong buy, 15 buy, 1 hold, 0 sell and 0 strong sell.

How many Madrigal Pharmaceuticals shares are sold short?

As reported by the data feed, 2.14M shares were sold short, 10.80% of the float as of Oct 30, 2026. At the average daily volume that is 7.25 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Madrigal Pharmaceuticals stock?

As reported by the data feed, institutions hold 98.3% of the shares (594 institutions) and insiders 5.8%. There are 23.23M shares outstanding, of which 13.96M are in the float.

How much does Madrigal Pharmaceuticals stock move with the market?

Its beta, as reported by the data feed, is -1: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $353.54 and $615.00.

Cite this page

Funkfolio, “Madrigal Pharmaceuticals (MDGL) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/MDGL/statistics

Underlying data: Yahoo Finance.